REGN Regeneron Pharmaceuticals, Inc.

NASDAQ
$945.53

Regeneron Pharmaceuticals, Inc. (REGN) SEC Filings

Everything REGN has filed with the SEC, newest first. An 8-K shows what it was about where we have classified it — an earnings release and a change of chief executive are both 8-Ks, and the form number alone doesn't separate them.

95 filings
Date Form Filing
4
4
4
144
144
144
144
4
4
4
144
4
144
4
144
4
144
144
144
144
144
144
10-Q
8-K Earnings Release · Guidance Update · Material Agreement
4
144
8-K Earnings Release · Guidance Update · Material Agreement · Other Event · Other Reg Fd · Preliminary Results
8-K Executive Change · Other
4
4
144
144
144
4
4
4
4
10-Q
4
4
10-Q
4
4
4
4
4
10-K
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q

Filings are sourced from EDGAR and open on the SEC's own site. Classification of 8-K events is ours and is not part of the filing.